Ahmet ADİGUZEL, Mustafa AKAN, Sibel CİPLAK

Investigation of the Relationship between Headache and Anxiety during the Late COVID-19 Pandemic Period: A Prospective Case-Control Study

Objective: The effects of the COVID-19 pandemic on both the physical and psychological well-being of individuals have not yet been clearly understood. Especially during the early period of the pandemic, the most prevalent psychological effects included fear, preoccupation with health, anxiety, and feeling of loneliness caused by a general sense of uncertainty. The incidence of headache was as high as 70% among the mild COVID-19 cases. Findings from the past coronavirus outbreaks indicated that neuropsychiatric symptoms might cause a significant health burden and adversely affect the patients’ quality of life. The present study aimed to investigate the anxiety-related clinical conditions of the patients diagnosed with primary headache, who presented to the neurology polyclinic during the prolonged pandemic period. Methods: The research was designed as a two-center, prospective case-control study. Patients diagnosed with primary headache, who presented to the neurology outpatient clinic, and healthy volunteers without a primary headache diagnosis were included in the study. Data collection tools included the sociodemographic data form, Headache Impact Test, Coronavirus Anxiety Scale Short Form, and COVID-19 Disease Perception Scale. Results: Data collected from a total of 869 participants, including 408 (47%) patients diagnosed with headache and 461 (53%) healthy volunteers, were investigated. The results of the Headache Impact Test-6 suggested a severe effect on quality of life in 187 participants (45.8%) in the headache group and 73 participants (15.8%) in the Control Group (p=0.001). There was coronavirus anxiety in 59 (14.5%) participants with headache and 8 (1.7%) participants in the Control Group (p=0.001). Furthermore, the rate of coronavirus anxiety in participants that had and did not have COVID-19 was 44 (13.7%) and 22 (4.1%), respectively (p=0.001). Conclusion: The study results revealed that patients with headache and COVID-19 presented with a higher rate of coronavirus anxiety than healthy controls and those not diagnosed with COVID-19. Further studies on larger samples are necessary for investigating the long term neuropsychiatric effects of COVID-19 in individuals.

Keywords:

COVID-19, neuropsychiatry headache, anxiety, HIT-6,

PDF

___

1. Bolay H, Gül A, Baykan B. COVID 19 is a real headache!. Headache 2020; 60: 1415-21.
2. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: A systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91-95.
3. Akan M, Akan A, Aydin Y, et al. Evaluation of healthcare workers in terms of burnout and psychiatric symptoms during the COVID-19 pandemic. Medicine 2021; 10: 1151-8.
4. Gica S, Kavakli M, Durduran Y, Ak M. The effect of COVID-19 pandemic on psychosomatic complaints and investigation of the mediating role of intolerance to uncertainty, biological rhythm changes and perceived COVID-19 threat in this relationship: A web-based community survey. Psychiatr Clin Psychopharmacol 2020; 89-96.
5. Kucuk A, Vatansev H, Gica S, et al. Effects of COVID 19 pandemic on psychological condition and disease severity in patients with Behçet’s Disease. PBS 2020; 10: 168-77.
6. Li Z, Ge J, Yang M, et al. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav Immun 2020; 88: 916-9.
7. Banerjee D, Viswanath B. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses. Asian J Psychiatr 2020; 54: 102350.
8. Correia AO, Feitosa PWG, de Sousa Moreira JL, et al. Neurological manifestations of COVID-19 and other coronaviruses: A systematic review. Neurol Psychiatry Brain Res 2020; 37: 27-32.
9. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurol 2020 ;77: 683-90.
10. Mutiawati E, Syahrul S, Fahriani M, et al. Global prevalence and pathogenesis of headache in COVID 19: A systematic review and meta-analysis. F1000Res 2020; 9: 1316-37
11. Bell M, Taub D, Perry V. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 1996; 74: 283-92.
12. Kaplanski G, Teysseire N, Farnarier C, et al. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha dependent pathway. J Clin Investig 1995; 96: 2839- 44.
13. Dodick DW. A phase-by-phase review of migraine pathophysiology. J Headache Pain 2018; 58: 4-16.
14. Abboud H, Abboud FZ, Kharbouch H, et al. COVID-19 and SARS-Cov-2 infection: Pathophysiology and clinical effects on the nervous system. World neurosurg 2020; 140: 49-53.
15. Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr 2020; 52: 102066-71.
16. de Medeiros Carvalho PM, Moreira MM, de Oliveira MNA, et al. The psychiatric impact of the novel coronavirus outbreak. Psychiatry Res 2020; 286: 112902.
17. Fung TS, Liu DX. Coronavirus infection, ER stress, apoptosis and innate immunity. Front Microbiol 2014; 5: 296.
18. Honigsbaum M: A history of the great influenza pandemics: death, panic and hysteria, 1830-1920. IB Tauris 2013; 30: 313-21.
19. Bayliss M, Dewey J, Dunlap I, et al. A study of the feasibility of Internet administration of a computerized health survey: The Headache Impact Test (HIT™). Qual Life Res 2003; 12: 953-61.
20. Yalınay Dikmen P, Bozdag M, Gunes MH, et al. Reliability and validity of Turkish version of Headache Impact Test (HIT-6) in patients with migraine. Arch Neuropsychiatry 2020: 58; 300-07.
21. Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Stud 2020; 44: 393-401.
22. Biçer İ, Çakmak C, Demir H, et al. Coronavirus Anxiety Scale Short Form: Turkish Validity and Reliability Study. Anatol Clin 2020; 25: 216-25.
23. Geniş B, Gürhan N, Koç M, et al. Development of perception and attitude scales related with COVID 19 pandemia. PearsonJournal 2020; 5: 306-28.
24. Yavuz BG. Baş ağrısı olgularında psikiyatrik sorunlar. J Neurol-Special Topics 2016; 9: 34-7.
25. Nimnuan C, Asawavichienjinda T, Srikiatkhachorn A. Potential risk factors for psychiatric disorders in patients with headache. Headache 2012; 52: 90-8.
26. Jahangir S, Adjepong D, Al-Shami HA, Malik BH. Is there an association between migraine and major depressive disorder? A narrative review. Cureus 2020; 12: 8551-58
27. Baskin S, Smitherman TA. Migraine and psychiatric disorders: Comorbidities, mechanisms, and clinical applications. J Neurol Sci 2009; 30: 61-5.
28. Amoozegar F. Depression comorbidity in migraine. Int Rev Psychiatry 2017; 29: 504-15.
29. Yavuz BG, Aydinlar EI, Dikmen PP, Incesu C. Association between somatic amplification, anxiety, depression, stress and migraine. J Headache Pain 2013; 14: 1-6.
30. Koc M, Seyran F, Genis B, et al. The effect of perceptions and attitudes regarding COVID-19 on somatization symptoms and empathy skills. J Psychiatry Behav. Sci 2021; 11: 121-9.